TW201501694A - Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island - Google Patents

Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island Download PDF

Info

Publication number
TW201501694A
TW201501694A TW102123586A TW102123586A TW201501694A TW 201501694 A TW201501694 A TW 201501694A TW 102123586 A TW102123586 A TW 102123586A TW 102123586 A TW102123586 A TW 102123586A TW 201501694 A TW201501694 A TW 201501694A
Authority
TW
Taiwan
Prior art keywords
sample
receiving chamber
capillary
test strip
sample receiving
Prior art date
Application number
TW102123586A
Other languages
Chinese (zh)
Inventor
Lynsey Whyte
Scott Sloss
David Mccoll
Neil Whitehead
Antony Smith
Original Assignee
Lifescan Scotland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan Scotland Ltd filed Critical Lifescan Scotland Ltd
Priority to TW102123586A priority Critical patent/TW201501694A/en
Publication of TW201501694A publication Critical patent/TW201501694A/en

Links

Abstract

An analytical test strip for the determination of an analyte (such as glucose and/or hematocrit) in a bodily fluid sample (such as a whole blood sample) includes a first capillary sample-receiving chamber, a second capillary sample-receiving chamber, and a physical barrier island disposed between the first and second capillary sample-receiving chambers. Moreover, the physical island barrier is disposed such that bodily fluid sample flow between the first capillary sample-receiving chamber and the second capillary sample-receiving chamber is prevented during use of the analytical test strip.

Description

具有經實體障壁島分隔之毛細管試樣接受室的分析測試條 Analytical test strip with capillary sample receiving chamber separated by physical barrier islands

本發明一般係關於醫療裝置,特別是關於分析測試條及相關方法。 The present invention relates generally to medical devices, and more particularly to analytical test strips and related methods.

流體試樣中之分析物的測定(如偵檢及/或濃度測定)測體試樣之特徵(如血容比)特別受到醫療領域之關注。例如,會需要測定體液(如尿液、血液、血漿或間質液)之樣本中的葡萄糖、酮體、膽固醇、脂蛋白、三酸甘油酯、乙醯胺苯酚及/或HbA1c濃度。這類測定可使用例如目視、光測定或電化技術為基礎的分析測試條加以實現。習知電化學式分析測試條在例如美國專利第5,708,247號及第6,284,125號中敘述,該等案各者之全文以引用方式併入本文中。 Determination of analytes in fluid samples (eg, detection and/or concentration determination) The characteristics of the sample (eg, blood volume ratio) are of particular interest in the medical field. For example, it may be desirable to measure the concentration of glucose, ketone bodies, cholesterol, lipoproteins, triglycerides, acetaminophen, and/or HbA1c in a sample of body fluids such as urine, blood, plasma, or interstitial fluid. Such assays can be implemented using analytical test strips based on, for example, visual, photometric or electrochemical techniques. The conventional electrochemical analysis test strips are described, for example, in U.S. Patent Nos. 5,708,247 and 6,284,125, the entireties of each of each of each

本發明係有關於一種用於測定一體液試樣中之一分析物的分析測試條,該分析測試條包括:一第一毛細管試樣接受室;一第二毛細管試樣接受室;以及配置於該第一毛細管試樣接受室與該第二毛細管接受室之間的一實體障壁島,且其中該實體障壁島係 經配置使得在該分析測試條使用期間,防止體液試樣在該第一毛細管試樣接受室與該第二毛細管試樣接受室之間流動。 The present invention relates to an analytical test strip for determining an analyte in a one-piece liquid sample, the analytical test strip comprising: a first capillary sample receiving chamber; a second capillary sample receiving chamber; a physical barrier island between the first capillary sample receiving chamber and the second capillary receiving chamber, and wherein the physical barrier island The body fluid sample is prevented from flowing between the first capillary sample receiving chamber and the second capillary sample receiving chamber during use of the analytical test strip.

100‧‧‧電化學式分析測試條 100‧‧‧Electrochemical analysis test strip

120‧‧‧電絕緣基材層 120‧‧‧Electrically insulating substrate layer

140‧‧‧圖案化導體層 140‧‧‧ patterned conductor layer

140a‧‧‧電極 140a‧‧‧electrode

160‧‧‧圖案化絕緣層 160‧‧‧patterned insulation

180‧‧‧電極暴露窗 180‧‧‧Electrode exposure window

200‧‧‧酶試劑層 200‧‧‧Enzyme reagent layer

220‧‧‧圖案化間隔物層 220‧‧‧ patterned spacer layer

220a‧‧‧實體障壁島 220a‧‧‧Physical Barrier Island

240‧‧‧親水性層 240‧‧‧Hydrophilic layer

260‧‧‧頂層 260‧‧‧ top

262‧‧‧第一毛細管試樣接受室 262‧‧‧First capillary sample receiving chamber

264‧‧‧第二毛細管試樣接受室 264‧‧‧Second capillary sample receiving chamber

270a‧‧‧試樣施加開口 270a‧‧‧ sample opening

270b‧‧‧試樣施加開口 270b‧‧‧ sample opening

272a‧‧‧試樣施加開口 272a‧‧‧ sample opening

272b‧‧‧試樣施加開口 272b‧‧‧ sample opening

274‧‧‧第一共用試樣進入室 274‧‧‧First shared sample entry room

276‧‧‧第二共用試樣進入室 276‧‧‧Second shared sample entry room

600‧‧‧方法 600‧‧‧ method

610‧‧‧步驟 610‧‧‧Steps

620‧‧‧步驟 620‧‧‧Steps

630‧‧‧步驟 630‧‧ steps

640‧‧‧步驟 640‧‧‧Steps

650‧‧‧步驟 650‧‧ steps

併入本文且構成此說明書之一部分的附圖繪示本發明之目前較佳的實施例,並連同上文給定的【先前技術】及下文給定的【實施方式】共同用於解釋本發明的特徵,其中:圖1為根據本發明之一實施例之一電化學式分析測試條的簡化分解圖;圖2為圖1之電化學式分析測試條的各層之一系列簡化俯視圖;圖3為一簡化俯視圖,其代表圖1之電化學式分析測試條之基材層及間隔物層;圖4係圖1之電化學式分析測試條之一部分的簡化側視圖,為了清楚起見,省略其試劑層、圖案化絕緣層及圖案化導體層;圖5係圖1之電化學式分析測試條之簡化俯視圖,該圖繪示其不同成分;以及圖6為一流程圖,其繪示用於根據本發明之一實施例測定一體液試樣中之一分析物之方法的各階段。 The drawings, which are incorporated in and constitute a part of this specification, illustrate the presently preferred embodiments of the present invention, and together with the <RTIgt; 1 is a simplified exploded view of an electrochemical analysis test strip according to an embodiment of the present invention; and FIG. 2 is a simplified top view of one of the layers of the electrochemical analysis test strip of FIG. 1; Simplified top view, which represents the substrate layer and spacer layer of the electrochemical analysis test strip of FIG. 1; FIG. 4 is a simplified side view of a portion of the electrochemical analysis test strip of FIG. 1, for the sake of clarity, the reagent layer is omitted, a patterned insulating layer and a patterned conductor layer; FIG. 5 is a simplified top view of the electrochemical analysis test strip of FIG. 1, showing different components thereof; and FIG. 6 is a flow chart for illustrating the present invention. An embodiment of the various stages of the method of determining an analyte in a sample of a monolith.

必須參考圖式來閱讀以下的詳細說明,其中不同圖形中的相同元件具有相同編號。不必按照比例繪製的圖式繪示僅用於解釋目的的例示性實施例,且並未打算限制本發明的範圍。此詳細說明是以範例方式而非以限制方式來說明本發明的原理。此說明能使熟悉此項技術者得以製造並使用本發明,且其敘述本發明之若干 實施例、改變、變異、替代與使用,包括當前咸信為實行本發明之最佳模式者。 The following detailed description must be read with reference to the drawings in which the same elements in the different figures have the same number. The illustrations are not necessarily to scale, the illustrative embodiments are intended to be illustrative, and are not intended to limit the scope of the invention. The detailed description is to be construed as illustrative of illustrative embodiments This description enables those skilled in the art to make and use the invention, and The embodiments, changes, variations, substitutions and uses, including the current state of the art, are the best mode for carrying out the invention.

如本文所述,針對任何數值或範圍之「大約」或「近乎」的詞係指一適當的尺寸公差,其允許部件或部件之集合以在本文所述之意圖產生作用。 As used herein, the term "about" or "nearly" to any numerical value or range refers to a suitable dimensional tolerance that allows a component or collection of components to function in the intent described herein.

一般而言,根據本發明的實施例之用於測定體液試樣(例如全血)中之分析物(如葡萄糖及/或血容比)的分析測試條(例如電化學式分析測試條)包括第一毛細管試樣接受室、第二毛細管試樣接受室及配置於該第一及第二毛細管試樣接受室之間的實體障壁島。另外,該實體障壁島配置為能夠在該分析測試條使用期間,防止體液試樣在該第一毛細管試樣接受室與該第二毛細管試樣接受室之間流動。 In general, an analytical test strip (eg, an electrochemical assay test strip) for determining an analyte (eg, glucose and/or blood volume ratio) in a body fluid sample (eg, whole blood) according to an embodiment of the invention includes A capillary sample receiving chamber, a second capillary sample receiving chamber, and a physical barrier island disposed between the first and second capillary sample receiving chambers. Additionally, the physical barrier island is configured to prevent a body fluid sample from flowing between the first capillary sample receiving chamber and the second capillary sample receiving chamber during use of the analytical test strip.

根據本發明的實施例之分析測試條具有優點,例如該實體障壁島能維持該第一及第二毛細管試樣接受室之流體完整性,同時易於製造。該流體完整性有利地防止該第一及第二毛細管試樣接受室之間的試劑及反應副產物混合,以避免導致不正確的分析物或體液試樣特徵測定。另外,由於該實體障壁島可相對小型,因此該第一及第二毛細管試樣接受室之試樣施加開口可互相靠近並置(例如相隔約250微米之距離,該距離可由大約1微升之全血樣本可操作性橋接),如此單次施加體液試樣可橋接該兩個試樣施加開口且充滿該第一及第二毛細管試樣接受室。另外,該實體障壁島可以相對簡單且不昂貴之方式,利用習用製造技術製造。 Analytical test strips in accordance with embodiments of the present invention have advantages in that, for example, the physical barrier islands maintain fluid integrity of the first and second capillary sample receiving chambers while being easy to manufacture. The fluid integrity advantageously prevents mixing of reagents and reaction byproducts between the first and second capillary sample receiving chambers to avoid causing incorrect analyte or body fluid sample characterization. In addition, since the physical barrier islands can be relatively small, the sample application openings of the first and second capillary sample receiving chambers can be juxtaposed to each other (for example, a distance of about 250 micrometers apart, which can be about 1 microliter. The blood sample is operatively bridged, such that a single application of the body fluid sample bridges the two sample application openings and fills the first and second capillary sample receiving chambers. Additionally, the physical barrier islands can be manufactured using conventional manufacturing techniques in a relatively simple and inexpensive manner.

圖1為根據本發明之一實施例的一電化學式分析測試條100的簡化分解圖。圖2為電化學式分析測試條100的各層之一 系列簡化俯視圖。圖3代表電化學式分析測試條100的基材層及間隔物層(其一部分係經建構為實體障壁島)之簡化俯視圖。圖4係電化學式分析測試條100之一部分的簡化側視圖,為了清楚起見,省略其試劑層、圖案化絕緣層及圖案化導體層。圖5係電化學式分析測試條100之簡化俯視圖,該圖繪示其不同組件(包括電極)。 1 is a simplified exploded view of an electrochemical analysis test strip 100 in accordance with an embodiment of the present invention. 2 is one of the layers of the electrochemical analysis test strip 100 The series simplifies the top view. 3 is a simplified top plan view of a substrate layer and a spacer layer (a portion of which is constructed as a solid barrier island) of the electrochemical analysis test strip 100. 4 is a simplified side view of a portion of an electrochemical analysis test strip 100 with the reagent layer, patterned insulating layer, and patterned conductor layer omitted for clarity. Figure 5 is a simplified top plan view of an electrochemical analysis test strip 100 showing its various components (including electrodes).

參考圖1至5,用於測定一體液試樣(例如,全血試樣)中之一分析物(例如,葡萄糖)之電化學式分析測試條100包括電絕緣基材層120、圖案化導體層140、在其中具有電極暴露窗180的圖案化絕緣層160、酶試劑層200、包括實體障壁島220a之圖案化間隔物層220、親水性層240及頂層260。 Referring to Figures 1 through 5, an electrochemical analysis test strip 100 for determining an analyte (e.g., glucose) in an integral liquid sample (e.g., a whole blood sample) includes an electrically insulating substrate layer 120, a patterned conductor layer 140. A patterned insulating layer 160 having an electrode exposure window 180 therein, an enzyme reagent layer 200, a patterned spacer layer 220 including a physical barrier island 220a, a hydrophilic layer 240, and a top layer 260.

電化學式分析測試條100之電絕緣基材層120、圖案化導體層140(其包括多個電極140a,特別見圖5)、圖案化絕緣層160、酶試劑層200、圖案化間隔物層220(及其實體障壁島220a)、親水性層240及頂層260的配置及對準,致使界定電化學式分析測試條100之第一毛細管試樣接受室262及第二毛細管試樣接受室264。 Electrochemically analyzing the electrically insulating substrate layer 120 of the test strip 100, the patterned conductor layer 140 (which includes a plurality of electrodes 140a, particularly see FIG. 5), the patterned insulating layer 160, the enzyme reagent layer 200, and the patterned spacer layer 220 The configuration and alignment of (and its physical barrier islands 220a), hydrophilic layer 240, and top layer 260 results in defining a first capillary sample receiving chamber 262 and a second capillary sample receiving chamber 264 of the electrochemical analysis test strip 100.

實體障壁島220a係配置於第一毛細管試樣接受室262與第二毛細管試樣接受室264之間,致使防止液體在電化學式分析測試條100的使用期間在兩者之間流動。 The solid barrier islands 220a are disposed between the first capillary sample receiving chamber 262 and the second capillary sample receiving chamber 264, thereby preventing liquid from flowing between the two during use of the electrochemical analysis test strip 100.

應注意在圖1至5所繪示之實施例中,該實體障壁島基本上係配置於與充滿該第一及第二毛細管試樣接受室之體液的主要流動方向平行。因此,該實體障壁島不妨礙體液充滿該第一及第二毛細管試樣接受室,而是防止已進入任一毛細管試樣接受室之體液進入另一毛細管試樣接受室。 It should be noted that in the embodiment illustrated in Figures 1 through 5, the physical barrier islands are disposed substantially parallel to the main flow direction of bodily fluids filled with the first and second capillary sample receiving chambers. Therefore, the physical barrier island does not prevent the body fluid from filling the first and second capillary sample receiving chambers, but prevents the body fluid that has entered any of the capillary sample receiving chambers from entering the other capillary sample receiving chamber.

在圖4之透視圖中,第一及第二毛細管試樣接受室262及264具有約100μm之高度,自約1.45mm至1.65mm之寬度,及約2.55mm之斜角。產生停止接面之垂直方向突然改變係約100μm之額外高度。 In the perspective view of Fig. 4, the first and second capillary sample receiving chambers 262 and 264 have a height of about 100 μm, a width of from about 1.45 mm to 1.65 mm, and an oblique angle of about 2.55 mm. The sudden change in the vertical direction in which the stop joint is generated is an additional height of about 100 μm.

電化學式分析測試條100之圖案化導體層140(包括電極140a)可由任何適用的導體材料形成,包括例如金、鈀、鉑、銦、鈦鈀合金及導電性碳基材料包括碳墨。特別參照圖5,圖案化絕緣層160之電極曝露窗180暴露在該圖較下方部分之三根電極140a(例如相對/參考電極及第一和第二工作電極),其係經建構以用於電化學測定體液試樣(全血)中之分析物(葡萄糖)。電極曝露窗180亦暴露經建構以用於測定全血血容比之二根電極(在該圖之較上方部分)。使用分析測試條之電極測定血容比係描述於例如美國專利申請案61/581,100、61/581,097、61/581,089、61/530,795及61/530,808號,上述各案完整內容均於此合併參照。 The patterned conductor layer 140 (including electrode 140a) of the electrochemical analysis test strip 100 can be formed from any suitable conductor material including, for example, gold, palladium, platinum, indium, titanium palladium alloys, and conductive carbon-based materials including carbon ink. Referring specifically to Figure 5, the electrode exposure window 180 of the patterned insulating layer 160 is exposed to three electrodes 140a (e.g., opposing/reference electrodes and first and second working electrodes) in the lower portion of the Figure, which are constructed for electrochemical use. The analyte (glucose) in the body fluid sample (whole blood) was measured. The electrode exposure window 180 also exposes two electrodes (in the upper portion of the figure) that are constructed for determining the whole blood volume ratio. The determination of the blood volume ratio using the electrodes of the analytical test strips is described in, for example, U.S. Patent Application Serial Nos. 61/581, 100, 61/581, 097, 61/581, 089, 61/530, 795, and 61/530, 808, the entire contents of each of which are incorporated herein by reference.

在使用時,體液試樣係施加於電化學式分析測試條100並藉由毛細作用充滿第一及第二毛細管試樣接受室,藉此操作性接觸配置於該第一及第二毛細管試樣接受室中之電極。特別參照圖3,第一毛細管試樣接受室262具有至少一試樣施加開口(亦即二個開口270a及270b),第二毛細管試樣接受室264具有至少一試樣施加開口(亦即二個試樣施加開口272a及272b)。該第一及第二毛細管試樣接受室之各者係經建構以使得試樣可自該分析測試條之左手邊(使用試樣施加開口270a及272a)或右手邊(使用試樣施加開口270b及272b)被施加及充滿二個毛細管試樣接受室。在任一種情況下,該第一毛細管試樣接受室之試樣施加開口及該第二毛 細管試樣接受室之試樣施加開口係經並置,以使得單一體液試樣可被同時施加至其中。 In use, a body fluid sample is applied to the electrochemical analysis test strip 100 and filled with the first and second capillary sample receiving chambers by capillary action, whereby the operative contact is disposed in the first and second capillary sample receiving The electrode in the chamber. With particular reference to Figure 3, the first capillary sample receiving chamber 262 has at least one sample application opening (i.e., two openings 270a and 270b), and the second capillary sample receiving chamber 264 has at least one sample application opening (i.e., two The samples are applied with openings 272a and 272b). Each of the first and second capillary sample receiving chambers is constructed such that the sample can be from the left hand side of the analytical test strip (using the sample application openings 270a and 272a) or the right hand side (using the sample application opening 270b) And 272b) are applied and filled with two capillary sample receiving chambers. In either case, the sample application opening of the first capillary sample receiving chamber and the second hair The sample application opening of the thin tube sample receiving chamber is juxtaposed so that a single body fluid sample can be simultaneously applied thereto.

在圖1至5之實施例中,實體障壁島220a之寬度小於該電化學式分析測試條之寬度(特別參照圖3,其中「寬度」在此上下文中係指圖3之觀點的水平方向)。換句話說,雖然實體障壁島220a係沿著該第一及第二毛細管試樣接受室縱向配置,該實體障壁島不延伸至該電化學式分析測試條之側邊邊緣。 In the embodiment of Figures 1 to 5, the width of the physical barrier island 220a is less than the width of the electrochemical analysis test strip (see, in particular, Figure 3, where "width" in this context refers to the horizontal direction of the view of Figure 3). In other words, although the physical barrier islands 220a are longitudinally disposed along the first and second capillary sample receiving chambers, the physical barrier islands do not extend to the side edges of the electrochemical analysis test strip.

前述實體障壁島220a之較小寬度及配置,界定在該第一毛細管試樣接受室262之第一試樣施加開口270a與該第二毛細管試樣接受室264之第一試樣施加開口272a處之第一共用試樣進入室274,以及在該第一毛細管試樣接受室262之第二試樣施加開口270b與該第二毛細管試樣接受室264之第二試樣施加開口272b處之第二共用試樣進入室276。為了清楚起見,圖3中第一及第二共用試樣進入室274及276之區域係以斜線顯示。 The smaller width and arrangement of the physical barrier islands 220a are defined at the first sample application opening 270a of the first capillary sample receiving chamber 262 and the first sample application opening 272a of the second capillary sample receiving chamber 264. The first common sample entering chamber 274, and the second sample applying opening 270b of the first capillary sample receiving chamber 262 and the second sample applying opening 272b of the second capillary sample receiving chamber 264 The second shared sample enters chamber 276. For the sake of clarity, the areas of the first and second common sample entering chambers 274 and 276 in Figure 3 are shown in oblique lines.

第一共用試樣進入室274及第二共用試樣進入室276之優點在於,舉例來說,施加之體液試樣可更輕易地克服表面張力以充滿該單一共用試樣進入室(進而充滿該第一及第二毛細管試樣接受室),相較於必須克服二個分開之試樣進入室之表面張力。此外,該第一及第二共用試樣進入室各者之寬度(在此上下文係指圖3之垂直方向)大於該第一或第二試樣施加開口各者之寬度,也大於二個第一試樣施加開口之寬度的總和,或二個第二試樣施加開口之寬度的總和。因此,使用者可更容易地施加體液試樣至該相對較大之寬度,相較於毛細管試樣接受室之試樣施加開口的寬度而言。 The first common sample entry chamber 274 and the second common sample entry chamber 276 have the advantage that, for example, the applied body fluid sample can more easily overcome the surface tension to fill the single common sample into the chamber (and thus fill the chamber) The first and second capillary sample receiving chambers are compared to the surface tension of the two separate sample entering chambers. In addition, the width of each of the first and second common sample entering chambers (in this context, the vertical direction of FIG. 3) is greater than the width of each of the first or second sample applying openings, and is greater than two The sum of the widths of a sample application opening, or the sum of the widths of the two second sample application openings. Therefore, the user can more easily apply the body fluid sample to the relatively large width, as compared to the width of the sample application opening of the capillary sample receiving chamber.

電絕緣基材層120可為一熟悉此項技術者已知的任何適用的電絕緣基材層,包括例如耐綸基材、聚碳酸酯基材、聚醯亞胺基材、聚氯乙烯基材、聚乙烯基材、聚丙烯基材、甘醇酸鹽化聚酯(PETG)基材或聚酯基材。電絕緣基材層可具有任何適用的尺寸,包括例如約5mm的寬度尺寸、約27mm的長度尺寸及約0.35mm的厚度尺寸。 The electrically insulating substrate layer 120 can be any suitable electrically insulating substrate layer known to those skilled in the art including, for example, nylon substrates, polycarbonate substrates, polyimide substrates, polyvinyl chloride Material, polyethylene substrate, polypropylene substrate, glycolated polyester (PETG) substrate or polyester substrate. The electrically insulating substrate layer can have any suitable dimensions including, for example, a width dimension of about 5 mm, a length dimension of about 27 mm, and a thickness dimension of about 0.35 mm.

電絕緣基材層120提供條容易處理的結構,且亦作為用於施加(例如,印刷或沉積)後續層(例如,圖案化導體層)的基底。須注意用在根據本發明之實施例之分析測試條中的圖案化導體層可採取任何適用的形狀,並由任何適用的材料形成,包括例如金屬材料及導電碳材料。 The electrically insulating substrate layer 120 provides a structure that is easy to handle, and also serves as a substrate for applying (eg, printing or depositing) a subsequent layer (eg, a patterned conductor layer). It is noted that the patterned conductor layer used in the analytical test strip in accordance with embodiments of the present invention can take any suitable shape and be formed from any suitable material, including, for example, metallic materials and conductive carbon materials.

圖案化絕緣層160可由例如可網版印刷的絕緣墨水形成。這一類可網版印刷的絕緣墨水商業上可購自Ercon(設址於Wareham,Massachusetts U.S.A.),其係以「Insulayer」的名稱銷售。 The patterned insulating layer 160 may be formed of, for example, screen-printable insulating ink. This type of screen-printable insulating ink is commercially available from Ercon (located at Wareham, Massachusetts U.S.A.) and sold under the name "Insulayer".

圖案化間隔物層220可由例如Apollo Adhesives,Tamworth,Staffordshire銷售之可網版印刷之感壓黏著劑形成,或其他適用之材料如聚酯及聚丙烯形成。圖案化間隔物層220之厚度可為例如75μm。在圖1至5之實施例中,圖案化間隔物層220界定該第一及第二毛細管試樣接受室280之外壁。 The patterned spacer layer 220 can be formed, for example, from a screen printable pressure sensitive adhesive sold by Apollo Adhesives, Tamworth, Staffordshire, or other suitable materials such as polyester and polypropylene. The thickness of the patterned spacer layer 220 can be, for example, 75 μm. In the embodiment of Figures 1-5, the patterned spacer layer 220 defines the outer walls of the first and second capillary sample receiving chambers 280.

親水性層240可為例如具有親水性質的清透薄膜,其促進藉由流體試樣(例如,全血試樣)的潤濕及填充電化學式分析測試條100。該清透薄膜可購自例如3M(Minneapolis,Minnesota U.S.A.)及Coveme(San Lazzaro di Savena,Italy)。親水性層240可為例如塗覆界面活性劑之聚酯膜,該界面活性劑提供小於10度之親水性接觸 角。親水性層240亦可為塗覆界面活性劑或其他表面處理例如MESA塗層之聚丙烯膜。親水性層240可具有例如約100μm之厚度。 The hydrophilic layer 240 can be, for example, a clear film having hydrophilic properties that facilitates wetting and filling of the electrochemical test strip 100 by a fluid sample (eg, a whole blood sample). The clear film is commercially available, for example, from 3M (Minneapolis, Minnesota U.S.A.) and Coveme (San Lazzaro di Savena, Italy). The hydrophilic layer 240 can be, for example, a polyester film coated with a surfactant that provides less than 10 degrees of hydrophilic contact. angle. The hydrophilic layer 240 can also be a polypropylene film coated with a surfactant or other surface treatment such as a MESA coating. The hydrophilic layer 240 may have a thickness of, for example, about 100 μm.

在酶試劑的選擇取決於欲測定之分析物的情況下,酶試劑層200可包括任何適用的酶試劑。例如,若欲測定血液試樣中之葡萄糖,酶試劑層200可包括葡萄糖氧化酶或葡萄糖脫氫酶與針對功能性操作所必需的其他組分。酶試劑層200可包括例如葡萄糖氧化酶、三檸檬酸鈉、檸檬酸、聚乙烯醇、羥乙基纖維素、亞鐵氰化鉀、消泡劑、膠態氧化矽、PVPVA及水。關於酶試劑層及電化學式分析測試條之一般性的進一步細節在美國專利第6,241,862號及第6,733,655號中,該等全文內容以引用方式併入本文中。 Where the choice of enzyme reagent depends on the analyte to be assayed, the enzyme reagent layer 200 can include any suitable enzyme reagent. For example, to determine glucose in a blood sample, the enzyme reagent layer 200 can include glucose oxidase or glucose dehydrogenase with other components necessary for functional operation. The enzyme reagent layer 200 may include, for example, glucose oxidase, sodium tricitrate, citric acid, polyvinyl alcohol, hydroxyethyl cellulose, potassium ferrocyanide, an antifoaming agent, colloidal cerium oxide, PVPVA, and water. Further details regarding the generality of the enzyme reagent layer and the electrochemical analysis test strip are described in U.S. Patent Nos. 6,241,862 and 6,733, 655 each incorporated herein by reference.

頂層260可由任何適用之材料形成,包括例如聚酯材料、聚丙烯材料及其他塑膠材料。頂層260可具有例如約50μm之厚度。 The top layer 260 can be formed from any suitable material, including, for example, polyester materials, polypropylene materials, and other plastic materials. The top layer 260 can have a thickness of, for example, about 50 [mu]m.

可例如藉由在電絕緣基材層120上循序對準地形成圖案化導體層140、圖案化絕緣層160、酶試劑層200、圖案化間隔物層220、親水性層240及頂層260來製造電化學式分析測試條100。一熟悉此項技術者已知之任何適用的技術可用於實現這類循序對準的形成,包括例如網版印刷、微影、凹版印刷、化學蒸氣沉積及捲帶層壓技術。 Manufacture can be made, for example, by sequentially forming patterned conductor layer 140, patterned insulating layer 160, enzymatic reagent layer 200, patterned spacer layer 220, hydrophilic layer 240, and top layer 260 on electrically insulating substrate layer 120. The test strip 100 is electrochemically analyzed. Any suitable technique known to those skilled in the art can be used to effect such sequential alignment formation, including, for example, screen printing, lithography, gravure printing, chemical vapor deposition, and tape lamination techniques.

圖6之流程圖說明本發明之一實施例之方法600的各階段,該方法係用於測定一體液試樣(例如,全血樣本)中之分析物(諸如葡萄糖)及/或該體液試樣之一特徵(例如血容比)。方法600包括(見圖6之步驟610)施加一體液試樣至一分析測試條,以使所施加之該體液試樣充滿該分析測試條之一第一毛細管試樣接受 室及一第二毛細管試樣接受室,及藉由該分析測試條之一實體障壁島防止所施加之該體液試樣在該第一毛細管試樣接受室與該第二毛細管試樣接受室之間流動。 Figure 6 is a flow chart illustrating stages of a method 600 of an embodiment of the present invention for determining an analyte (such as glucose) and/or a body fluid test in a sample of a unitary fluid (e.g., a whole blood sample). One of the characteristics (such as blood volume ratio). The method 600 includes (see step 610 of FIG. 6) applying an integral liquid sample to an analytical test strip such that the applied body fluid sample is filled with the first capillary sample of the analytical test strip. a chamber and a second capillary sample receiving chamber, and preventing the applied body fluid sample from being in the first capillary sample receiving chamber and the second capillary sample receiving chamber by a physical barrier island of the analytical test strip Flow between.

方法600亦包括測量該分析測試條之一第一反應(例如來自該第一毛細管試樣接受室中之電極的一電化學反應)及基於該測量的第一電化學反應測定該體液試樣中之一分析物(見圖6之步驟620及630)。 The method 600 also includes measuring a first reaction of the analytical test strip (eg, an electrochemical reaction from an electrode in the first capillary sample receiving chamber) and determining the body fluid sample based on the measured first electrochemical reaction One of the analytes (see steps 620 and 630 of Figure 6).

方法600之步驟640及650亦包括測量該分析測試條之一第二反應(例如來自該第二毛細管試樣接受室中之電極的一電反應)及基於該測量的第二反應測定該體液試樣之一特徵。上述測量及測定步驟(若有需要)可利用適當之相關儀表進行,測量步驟620及630可以任何適當順序或重疊方式進行。 Steps 640 and 650 of method 600 also include measuring a second reaction of the analytical test strip (eg, an electrical reaction from an electrode in the second capillary sample receiving chamber) and determining the body fluid test based on the second reaction of the measurement One of the characteristics. The above measurement and measurement steps, if desired, may be performed using appropriate associated meters, and measurement steps 620 and 630 may be performed in any suitable order or in an overlapping manner.

一旦獲悉本揭示內容,熟悉此項技術者將理解到可輕易修改方法600,以根據本發明之實施例以及本文所述併入分析測試條之任何技術、優點與特性。 Upon reading this disclosure, those skilled in the art will appreciate that the method 600 can be readily modified to incorporate any of the techniques, advantages and features of the analytical test strips in accordance with embodiments of the present invention and as described herein.

雖然已在本文顯示及敘述本發明的較佳實施例,但是熟悉此項技術者當明白此類實施例僅經由實例提供。在不偏離本發明的情況下,熟悉此項技術者現將發想眾多變異、改變及置換物。須了解本文所述之本發明之實施例的各種替代可用於實行本發明。吾人意欲以下文的專利申請範圍定義本發明的範疇,並藉此涵蓋屬於專利申請範圍內的裝置、方法及其等同物。 While the preferred embodiment of the present invention has been shown and described herein, it is understood that Many variations, modifications, and substitutions will now occur to those skilled in the art without departing from the invention. It is to be understood that various alternatives to the embodiments of the invention described herein may be used to practice the invention. The scope of the invention is defined by the scope of the invention, which is intended to cover the scope of the invention.

100‧‧‧電化學式分析測試條 100‧‧‧Electrochemical analysis test strip

120‧‧‧電絕緣基材層 120‧‧‧Electrically insulating substrate layer

140‧‧‧圖案化導體層 140‧‧‧ patterned conductor layer

160‧‧‧圖案化絕緣層 160‧‧‧patterned insulation

180‧‧‧電極暴露窗 180‧‧‧Electrode exposure window

200‧‧‧酶試劑層 200‧‧‧Enzyme reagent layer

220‧‧‧圖案化間隔物層 220‧‧‧ patterned spacer layer

220a‧‧‧實體障壁島 220a‧‧‧Physical Barrier Island

240‧‧‧親水性層 240‧‧‧Hydrophilic layer

260‧‧‧頂層 260‧‧‧ top

Claims (20)

一種用於測定一體液試樣中之一分析物的分析測試條,該分析測試條包括:一第一毛細管試樣接受室;一第二毛細管試樣接受室;以及配置於該第一毛細管試樣接受室與該第二毛細管接受室之間的一實體障壁島,且其中該實體障壁島係經配置使得在該分析測試條使用期間,防止體液試樣在該第一毛細管試樣接受室與該第二毛細管試樣接受室之間流動。 An analytical test strip for determining an analyte in a one-piece liquid sample, the analytical test strip comprising: a first capillary sample receiving chamber; a second capillary sample receiving chamber; and a first capillary test a physical barrier island between the sample receiving chamber and the second capillary receiving chamber, and wherein the physical barrier island is configured to prevent a body fluid sample from being in the first capillary sample receiving chamber during use of the analytical test strip The second capillary sample receives flow between the chambers. 如申請專利範圍第1項之分析測試條,其中該第一毛細管試樣接受室具有至少一試樣施加開口且該第二試樣接受室具有至少一試樣施加開口,且其中該第一毛細管試樣接受室之試樣施加開口及該第二試樣接受室之試樣施加開口係經並置,以使得單一體液試樣可被同時施加至其中。 The analytical test strip of claim 1, wherein the first capillary sample receiving chamber has at least one sample application opening and the second sample receiving chamber has at least one sample application opening, and wherein the first capillary The sample application opening of the sample receiving chamber and the sample application opening of the second sample receiving chamber are juxtaposed such that a single body fluid sample can be simultaneously applied thereto. 如申請專利範圍第1項之分析測試條,其中該第一毛細管試樣接受室具有一第一試樣施加開口及一第二試樣施加開口,且其中該第二試樣接受室具有一第一試樣施加開口及一第二試樣施加開口。 The analytical test strip of claim 1, wherein the first capillary sample receiving chamber has a first sample application opening and a second sample application opening, and wherein the second sample receiving chamber has a first A sample application opening and a second sample application opening. 如申請專利範圍第3項之分析測試條,其中該實體障壁島沿著該第一毛細管試樣接受室及該第二毛細管試樣接受室縱向延伸。 The analytical test strip of claim 3, wherein the physical barrier island extends longitudinally along the first capillary sample receiving chamber and the second capillary sample receiving chamber. 如申請專利範圍第4項之分析測試條,其中該實體障壁島係經配置以使得: 一第一共用試樣進入室係被界定於該第一毛細管試樣接受室之第一試樣施加開口及該第二毛細管試樣接受室之第一試樣施加開口處,以及一第二共用試樣進入室係被界定於該第一毛細管試樣接受室之第二試樣施加開口及該第二毛細管試樣接受室之第二試樣施加開口處。 For example, in the analysis test strip of claim 4, wherein the physical barrier island is configured such that: a first common sample entering chamber is defined in the first sample applying opening of the first capillary sample receiving chamber and the first sample applying opening of the second capillary sample receiving chamber, and a second sharing The sample entry chamber is defined at a second sample application opening of the first capillary sample receiving chamber and a second sample application opening of the second capillary sample receiving chamber. 如申請專利範圍第5項之分析測試條,其中該第一共用試樣進入室之寬度係大於該第一毛細管試樣接受室之第一試樣施加開口與該第二毛細管試樣接受室之第一試樣施加開口之寬度的總和,且其中該第二共用試樣進入室之寬度係大於該第一毛細管試樣接受室之第二試樣施加開口與該第二毛細管試樣接受室之第二試樣施加開口之寬度的總和。 The analytical test strip of claim 5, wherein the width of the first common sample entering chamber is greater than the first sample applying opening of the first capillary sample receiving chamber and the second capillary receiving chamber a sum of widths of the first sample application openings, and wherein the width of the second common sample entry chamber is greater than the second sample application opening of the first capillary sample receiving chamber and the second capillary sample receiving chamber The sum of the widths of the second sample application openings. 如申請專利範圍第1項之分析測試條,其進一步包括:一電絕緣基材層;一圖案化導體層,其係配置於該電絕緣基材層之上,該圖案化導體層包含複數個電極;一圖案化絕緣層,其具有一第一電極曝露窗及一第二電極曝露窗;一酶試劑層,其係配置於該第一電極曝露窗及該第二電極曝露窗之至少一者之上;以及一圖案化間隔物層,一親水性層;以及一頂層, 其中至少該電絕緣基材層、圖案化絕緣層、圖案化間隔物層、親水性層及頂層界定該第一毛細管試樣接受室及該第二毛細管試樣接受室,以及其中該實體障壁島係該圖案化間隔物層之一部分。 The analytical test strip of claim 1, further comprising: an electrically insulating substrate layer; a patterned conductor layer disposed on the electrically insulating substrate layer, the patterned conductor layer comprising a plurality of An electrode; a patterned insulating layer having a first electrode exposure window and a second electrode exposure window; an enzyme reagent layer disposed in the first electrode exposure window and the second electrode exposure window Above; and a patterned spacer layer, a hydrophilic layer; and a top layer, Wherein at least the electrically insulating substrate layer, the patterned insulating layer, the patterned spacer layer, the hydrophilic layer and the top layer define the first capillary sample receiving chamber and the second capillary sample receiving chamber, and wherein the physical barrier island A portion of the patterned spacer layer. 如申請專利範圍第1項之分析測試條,其中該分析測試條係經建構為一電化學式分析測試條。 For example, the analytical test strip of claim 1 is constructed, wherein the analytical test strip is constructed as an electrochemical analysis test strip. 如申請專利範圍第1項之分析測試條,其中該體液試樣為一全血試樣。 For example, in the analytical test strip of claim 1, wherein the body fluid sample is a whole blood sample. 如申請專利範圍第1項之分析測試條,其中該分析物為葡萄糖。 For example, in the analytical test strip of claim 1, wherein the analyte is glucose. 如申請專利範圍第1項之分析測試條,其中該分析物為葡萄糖,且該分析測試條係經建構以測定被導入該第一毛細管試樣接受室之一體液試樣中之該分析物及被導入該第二毛細管試樣接受室之一體液試樣之血容比。 The analytical test strip of claim 1, wherein the analyte is glucose, and the analytical test strip is configured to determine the analyte introduced into the body fluid sample of the first capillary sample receiving chamber and The blood volume ratio of the body fluid sample introduced into the second capillary sample receiving chamber. 一種用於測定一體液試樣中之一分析物的方法,該方法包含以下步驟:施加一體液試樣至一分析測試條,以使所施加之該體液試樣充滿該分析測試條之一第一毛細管試樣接受室及一第二毛細管試樣接受室,及藉由一實體障壁島防止所施加之該體液試樣在該第一毛細管試樣接受室與該第二毛細管試樣接受室之間流動;測量該分析測試條之至少一第一反應;以及基於該第一測量的電化學反應測定該分析物。 A method for determining an analyte in an integral liquid sample, the method comprising the steps of: applying a one-piece liquid sample to an analytical test strip such that the applied body fluid sample is filled with one of the analytical test strips a capillary sample receiving chamber and a second capillary sample receiving chamber, and preventing the applied body fluid sample in the first capillary sample receiving chamber and the second capillary sample receiving chamber by a physical barrier island Flowing; measuring at least a first reaction of the analytical test strip; and determining the analyte based on the first measured electrochemical reaction. 如申請專利範圍第12項之方法,該方法進一步包括:測量該分析測試條之一第二反應,該第二反應取決於在該第二毛細管試樣接受室中的體液試樣,以及 基於該第二測量反應測定該體液試樣之一特徵。 The method of claim 12, the method further comprising: measuring a second reaction of the analytical test strip, the second reaction being dependent on a body fluid sample in the second capillary sample receiving chamber, and One of the characteristics of the body fluid sample is determined based on the second measurement reaction. 如申請專利範圍第12項之方法,其中該體液試樣為全血。 The method of claim 12, wherein the body fluid sample is whole blood. 如申請專利範圍第12項之方法,其中該分析物為葡萄糖。 The method of claim 12, wherein the analyte is glucose. 如申請專利範圍第12項中之方法,其中該施加步驟包括施加一單一體液試樣至該第一毛細管試樣接受室之一試樣施加開口及該第二試樣接受室之一試樣施加開口,且其中該第一毛細管試樣接受室之該試樣施加開口及該第二試樣接受室之該試樣施加開口係經並置,以使得該單一體液試樣可被同時施加至其中。 The method of claim 12, wherein the applying step comprises applying a single body fluid sample to one of the first capillary sample receiving chamber sample application opening and the second sample receiving chamber sample application An opening, and wherein the sample application opening of the first capillary sample receiving chamber and the sample application opening of the second sample receiving chamber are juxtaposed such that the single body fluid sample can be simultaneously applied thereto. 如申請專利範圍第16項之方法,其中該實體障壁島自該第一毛細管試樣接受室之該試樣施加開口與該第二毛細管試樣接受室之該試樣施加開口,沿著該第一毛細管試樣接受室及該第二毛細管試樣接受室縱向延伸。 The method of claim 16, wherein the physical barrier island is applied from the sample application opening of the first capillary sample receiving chamber to the sample application opening of the second capillary sample receiving chamber, along the first A capillary sample receiving chamber and the second capillary sample receiving chamber extend longitudinally. 如申請專利範圍第17項之方法,其中該實體障壁島係經配置以使得:一第一共用試樣進入室係被界定於該第一毛細管試樣接受室之該第一試樣施加開口及該第二毛細管試樣接受室之該第一試樣施加開口處,以及一第二共用試樣進入室係被界定於該第一毛細管試樣接受室之第二試樣施加開口及該第二毛細管試樣接受室之第二試樣施加開口處。 The method of claim 17, wherein the physical barrier island is configured such that: a first common sample entry chamber is defined by the first sample application opening of the first capillary sample receiving chamber and a first sample application opening of the second capillary sample receiving chamber, and a second common sample entry chamber defined by the second sample application opening of the first capillary sample receiving chamber and the second A second sample application opening of the capillary sample receiving chamber is provided. 如申請專利範圍第18項之方法,其中該第一共用試樣進入室之寬度係大於該第一毛細管試樣接受室之該第一試樣施加開口與 該第二毛細管試樣接受室之該第一試樣施加開口之寬度的總和,且其中該第二共用試樣進入室之寬度係大於該第一毛細管試樣接受室之該第二試樣施加開口與該第二毛細管試樣接受室之該第二試樣施加開口之寬度的總和。 The method of claim 18, wherein the width of the first common sample entry chamber is greater than the first sample application opening of the first capillary sample receiving chamber a sum of widths of the first sample application openings of the second capillary sample receiving chamber, and wherein the width of the second common sample entry chamber is greater than the second sample application of the first capillary sample receiving chamber The sum of the opening and the width of the second sample application opening of the second capillary sample receiving chamber. 如申請專利範圍第12項之方法,其中該分析測試條係經建構為一電化學式分析測試條。 The method of claim 12, wherein the analytical test strip is constructed as an electrochemical test strip.
TW102123586A 2013-07-02 2013-07-02 Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island TW201501694A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW102123586A TW201501694A (en) 2013-07-02 2013-07-02 Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW102123586A TW201501694A (en) 2013-07-02 2013-07-02 Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island

Publications (1)

Publication Number Publication Date
TW201501694A true TW201501694A (en) 2015-01-16

Family

ID=52718170

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102123586A TW201501694A (en) 2013-07-02 2013-07-02 Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island

Country Status (1)

Country Link
TW (1) TW201501694A (en)

Similar Documents

Publication Publication Date Title
US9528958B2 (en) Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island
EP2864494B1 (en) Electrochemical-based analytical test strip with intersecting sample-receiving chambers
TW201346255A (en) Electrochemical-based analytical test strip with fill-speed configured reagent layer
CN203535003U (en) Biosensor
JP6585636B2 (en) End-filled electrochemical analytical test strip with vertically intersecting sample receiving chambers
TW201403063A (en) Analytical test strip with capillary sample-receiving chambers separated by stop junctions
TWI610077B (en) Electrochemical-based analytical test strip and method for determining an analyte in a bodily fluid sample
TW201501694A (en) Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island
CN203534868U (en) Biosensor
US20160202204A1 (en) Electrochemical-based analytical test strip with ultra-thin discontinuous metal layer